Table 1: Distribution of the study population by gender for each ART regimen.

 

Women

Men

Total

n (%)

n (%)

Mean Age

n(%)

Mean Age

AZT + 3TC + NVP

16 (76.2)

42.2 ± 12.2

5 (23.8)

39.0 ± 9.3

21 (100)

AZT + TNF + NVP

5 (71.5)

47.2 ± 10.8

2 (28.5)

35.5 ± 12.0

7 (100)

3TC + TNF + EMB

14 (87.5)

40.0 ± 9.9

2 (12.5)

49.0 ± 11.2

16 (100)

D4T30 + 3TC + EFV

8 (80)

45.0 ± 12.6

2 (20)

39.5 ± 6.3

10 (100)

D4T40 + 3TC + NVP

9 (75)

45.1 ± 12.0

3 (25)

36.6 ± 7.5

12 (100)

ABC + 3TC + EFV

2 (66.7)

41.0 ± 15.5

1 (33.3)

60.0

3 (100)

TNF + 3TC + EFV

47 (63.5)

41.4 ± 11.2

27 (36.5)

43.0 ± 10.3

74 (100)

TNF + 3TC + EFV + CTM

20 (71.4)

41.6 ± 11.8

8 (28.6)

48.0 ± 5.3

28 (100)

TNF + 3TC + EFV + INH

6 (100)

45.4 ± 8.6

0 (0.0)

NA

6 (100)

TNF + 3TC + EFV + CTM + INH

3 (50)

41.7 ± 3.1

3 (50.0)

39.3 ± 8.9

6 (100)

TNF + 3TC

4 (100)

44.0 ± 6.6

0 (0.0)

NA

4 (100)

All regimen

134 (71.66)

42.3 ± 11.0

53 (28.34)

42.9 ± 10.0

187 (100)

NA: Not Applicable.